Literature DB >> 11709319

Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate.

N D Christensen1, C A Reed, T D Culp, P L Hermonat, M K Howett, R A Anderson, L J Zaneveld.   

Abstract

The high-molecular-weight sulfated or sulfonated polysaccharides or polymers cellulose sulfate, dextran sulfate, and polystyrene sulfonate were tested for microbicidal activity against bovine papillomavirus type 1 (BPV-1) and human papillomavirus type 11 (HPV-11) and type 40 (HPV-40). In vitro assays included the BPV-1-induced focus-forming assay and transient infection of human A431 cells with HPVs. The compounds were tested for microbicidal activity directly by preincubation with virus prior to addition to cell cultures and indirectly by addition of virus to compound-treated cells and to virus-coated cells to test inactivation of the virus after virus-cell binding. The data indicated that all three compounds showed direct microbicidal activity with 50% effective concentrations between 10 to 100 microg/ml. These concentrations were nontoxic to cell cultures for both assays. When a clone of C127 cells was tested for microbicidal activity, approximately 10-fold-less compound was required to achieve a 50% reduction in BPV-1-induced foci than for the uncloned parental C127 cells. Pretreatment of cells with compound prior to addition of virus also demonstrated strong microbicidal activity with dextran sulfate and polystyrene sulfonate, but cellulose sulfate required several orders of magnitude more compound for virus inactivation. Polystyrene sulfonate prevented subsequent infection of HPV-11 after virus-cell binding, and this inactivation was observed up to 4 h after addition of virus. These data indicate that the polysulfated and polysulfonated compounds may be useful nontoxic microbicidal compounds that are active against a variety of sexually transmitted disease agents including papillomaviruses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709319      PMCID: PMC90848          DOI: 10.1128/AAC.45.12.3427-3432.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  28 in total

1.  The promise of public/private sector collaboration in the development of vaginal microbicides.

Authors:  H L Gabelnick; M J Harper
Journal:  Int J Gynaecol Obstet       Date:  1999-12       Impact factor: 3.561

2.  Human papillomavirus infection requires cell surface heparan sulfate.

Authors:  T Giroglou; L Florin; F Schäfer; R E Streeck; M Sapp
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

3.  alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4.

Authors:  G Sibbet; C Romero-Graillet; G Meneguzzi; M S Campo
Journal:  J Gen Virol       Date:  2000-02       Impact factor: 3.891

4.  Evaluation of poly(styrene-4-sulfonate) as a preventive agent for conception and sexually transmitted diseases.

Authors:  R A Anderson; K Feathergill; X Diao; M Cooper; R Kirkpatrick; P Spear; D P Waller; C Chany; G F Doncel; B Herold; L J Zaneveld
Journal:  J Androl       Date:  2000 Nov-Dec

5.  In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency viruses.

Authors:  J Piret; J Lamontagne; J Bestman-Smith; S Roy; P Gourde; A Désormeaux; R F Omar; J Juhász; M G Bergeron
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

6.  A quantitative in vitro focus assay for bovine papilloma virus.

Authors:  I Dvoretzky; R Shober; S K Chattopadhyay; D R Lowy
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

7.  JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis.

Authors:  M T Pho; A Ashok; W J Atwood
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Poly(sodium 4-styrene sulfonate): an effective candidate topical antimicrobial for the prevention of sexually transmitted diseases.

Authors:  B C Herold; N Bourne; D Marcellino; R Kirkpatrick; D M Strauss; L J Zaneveld; D P Waller; R A Anderson; C J Chany; B J Barham; L R Stanberry; M D Cooper
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

9.  The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes.

Authors:  J G Joyce; J S Tung; C T Przysiecki; J C Cook; E D Lehman; J A Sands; K U Jansen; P M Keller
Journal:  J Biol Chem       Date:  1999-02-26       Impact factor: 5.157

10.  A human papilloma virus type 11 transcript encoding an E1--E4 protein.

Authors:  M Nasseri; R Hirochika; T R Broker; L T Chow
Journal:  Virology       Date:  1987-08       Impact factor: 3.616

View more
  37 in total

1.  Further evidence that papillomavirus capsids exist in two distinct conformations.

Authors:  Hans-Christoph Selinka; Tzenan Giroglou; Thorsten Nowak; Neil D Christensen; Martin Sapp
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Two novel vaginal microbicides (polystyrene sulfonate and cellulose sulfate) inhibit Gardnerella vaginalis and anaerobes commonly associated with bacterial vaginosis.

Authors:  Jose A Simoes; Diane M Citron; Alla Aroutcheva; Robert A Anderson; Calvin J Chany; Donald P Waller; Sebastian Faro; Lourens J D Zaneveld
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 3.  Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications.

Authors:  Allison H Bartlett; Pyong Woo Park
Journal:  Expert Rev Mol Med       Date:  2010-02-01       Impact factor: 5.600

4.  Structural basis of oligosaccharide receptor recognition by human papillomavirus.

Authors:  Jhimli Dasgupta; Malgorzata Bienkowska-Haba; Marcos E Ortega; Hetalkumar D Patel; Sabrina Bodevin; Dorothe Spillmann; Brooke Bishop; Martin Sapp; Xiaojiang S Chen
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

Review 5.  Role of heparan sulfate in sexually transmitted infections.

Authors:  Vaibhav Tiwari; Erika Maus; Ira M Sigar; Kyle H Ramsey; Deepak Shukla
Journal:  Glycobiology       Date:  2012-07-06       Impact factor: 4.313

6.  Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses.

Authors:  Manuela Donalisio; Marco Rusnati; Andrea Civra; Antonella Bugatti; Donatella Allemand; Giovanna Pirri; Andrea Giuliani; Santo Landolfo; David Lembo
Journal:  Antimicrob Agents Chemother       Date:  2010-07-19       Impact factor: 5.191

7.  Differential Sensitivity of Lactobacillus spp. to Inhibition by Candidate Topical Microbicides.

Authors:  Robert A Anderson; Alla Aroutcheva; Kenneth A Feathergill; Amillia B Anderson
Journal:  Probiotics Antimicrob Proteins       Date:  2009-03-04       Impact factor: 4.609

8.  Human alpha-defensins block papillomavirus infection.

Authors:  Christopher B Buck; Patricia M Day; Cynthia D Thompson; Jacek Lubkowski; Wuyuan Lu; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 9.  Non-specific microbicide product development: then and now.

Authors:  Joseph W Romano; Melissa Robbiani; Gustavo F Doncel; Thomas Moench
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

Review 10.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.